reference/16314907

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16314907

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2694
issn	1557-3265 1078-0432
issueIdentifier	9
pageRange	2687-2694
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	2687
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f9d878de052832230a3ba6c5a996d396 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4e2ad5af90276af59b19dbb7999b4daa http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_52d336d5245231e814353e212d17e669
bibliographicCitation	Banerji U, van Doorn L, Papadatos-Pastos D, Kristeleit R, Debnam P, Tall M, Stewart A, Raynaud F, Garrett MD, Toal M, Hooftman L, De Bono JS, Verweij J, Eskens FA. A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors. Clin Cancer Res. 2012 May 01;18(9):2687–94. doi: 10.1158/1078-0432.ccr-11-3165. PMID: 22553374.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9689636ac5bb8614609b1a7287ec1ec8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc8345ceb4c3f5f46048551ac5f48963 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92e50399904d90b2bb1fc6d839de7cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f42bc25b568209997337ef0cac372415 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37c6b9851d4addaa8b8189fe68c5d5e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dea02199528de3fe71997f126c1ac293 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddf67f6260a128da85e61c37c023337f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec0efc85d81256e5ab980052cb0ddf99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf55cb5b0fa4a95a78ce85505831598f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2660c48b210f31a3bb6d2f5c031618d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_151f4e030ab7724bdc4571e59daf3e86 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01aa7f35112a06f895231a3c9e567cb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7040531536469a3c5df8add1454031b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2494-4482 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af776458b75a1a2a72699e418ce780b9
date	2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22553374 https://doi.org/10.1158/1078-0432.ccr-11-3165
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
discusses	http://id.nlm.nih.gov/mesh/M0553848 http://id.nlm.nih.gov/mesh/M0499252 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0010420 http://id.nlm.nih.gov/mesh/M0527853
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D056572Q000627 http://id.nlm.nih.gov/mesh/D006655Q000737 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D053961Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D014018 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011743Q000493 http://id.nlm.nih.gov/mesh/D053961Q000493 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D056572Q000493 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D017322 http://id.nlm.nih.gov/mesh/D007963Q000166 http://id.nlm.nih.gov/mesh/D000107 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D007963Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49857317 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247407686 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID252166602 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 79.